Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways.

Autor:	Santa-Cecília FV; Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, UM75, U1127, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France.; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo (USP), Av. Bandeirantes 3900, CEP 14049-900, Ribeirão Preto, SP, Brazil., Socias B; Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, UM75, U1127, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France., Ouidja MO; Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, UM75, U1127, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France., Sepulveda-Diaz JE; Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, UM75, U1127, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France., Acuña L; Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, UM75, U1127, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France.; Instituto Superior de Investigaciones Biológicas, INSIBIO (CONICET-UNT) and Instituto de Química Biológica 'Dr Bernabé Bloj', Facultad de Bioquímica, Química y Farmacia (UNT), San Miguel de Tucumán, Tucumán, Argentina., Silva RL; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo (USP), Av. Bandeirantes 3900, CEP 14049-900, Ribeirão Preto, SP, Brazil., Michel PP; Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, UM75, U1127, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France., Del-Bel E; Department of Morphology, Physiology and Pathology, School of Odontology of Ribeirão Preto (FORP), University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Cunha TM; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo (USP), Av. Bandeirantes 3900, CEP 14049-900, Ribeirão Preto, SP, Brazil. thicunha@fmrp.usp.br., Raisman-Vozari R; Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, UM75, U1127, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France. ritaraisman@gmail.com.
Jazyk:	angličtina
Zdroj:	Neurotoxicity research [Neurotox Res] 2016 May; Vol. 29 (4), pp. 447-59. Date of Electronic Publication: 2016 Jan 08.
DOI:	10.1007/s12640-015-9592-2
Abstrakt:	In neurodegenerative diseases, the inflammatory response is mediated by activated glial cells, mainly microglia, which are the resident immune cells of the central nervous system. Activated microglial cells release proinflammatory mediators and neurotoxic factors that are suspected to cause or exacerbate these diseases. We recently demonstrated that doxycycline protects substantia nigra dopaminergic neurons in an animal model of Parkinson's disease. This effect was associated with a reduction of microglial cell activation, which suggests that doxycycline may operate primarily as an anti-inflammatory drug. In the present study, we assessed the anti-inflammatory potential of doxycycline using lipopolysaccharide (LPS)-activated primary microglial cells in culture as a model of neuroinflammation. Doxycycline attenuated the expression of key activation markers in LPS-treated microglial cultures in a concentration-dependent manner. More specifically, doxycycline treatment lowered the expression of the microglial activation marker IBA-1 as well as the production of ROS, NO, and proinflammatory cytokines (TNF-α and IL-1β). In primary microglial cells, we also found that doxycycline inhibits LPS-induced p38 MAP kinase phosphorylation and NF-kB nuclear translocation. The present results indicate that the effect of doxycycline on LPS-induced microglial activation probably occurs via the modulation of p38 MAP kinase and NF-kB signaling pathways. These results support the idea that doxycycline may be useful in preventing or slowing the progression of PD and other neurodegenerative diseases that exhibit altered glia function.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF